Clinical Trials Browser

Interventional × Neurotoxicity Syndromes × Vincristine × Clear all

NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2 Completed

91 enrolled 17 charts

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes

NCT00666484 2014-12-04

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Neurotoxicity Syndromes

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Phase EARLY_PHASE1 Withdrawn

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

NCT00001689 2008-03-04

A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma